Literature DB >> 18525273

Complete regression of HIV-associated multicentric Castleman disease treated with rituximab and thalidomide.

Georg Stary, Norbert Kohrgruber, Andreas M Herneth, Alexander Gaiger, Georg Stingl, Armin Rieger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18525273     DOI: 10.1097/QAD.0b013e3282fa75ce

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  10 in total

1.  High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.

Authors:  Thomas S Uldrick; Mark N Polizzotto; Karen Aleman; Deirdre O'Mahony; Kathleen M Wyvill; Victoria Wang; Vickie Marshall; Stefania Pittaluga; Seth M Steinberg; Giovanna Tosato; Denise Whitby; Richard F Little; Robert Yarchoan
Journal:  Blood       Date:  2011-04-12       Impact factor: 22.113

2.  Castleman's disease imitating adrenal mass in the retroperitoneal area.

Authors:  Gökhan Koç; Hakan Turk; Sıtkı Un; Cemal Selcuk Isoglu; Ferruh Zorlu
Journal:  Can Urol Assoc J       Date:  2015 Jan-Feb       Impact factor: 1.862

Review 3.  Castleman's disease: from basic mechanisms to molecular therapeutics.

Authors:  Hazem E El-Osta; Razelle Kurzrock
Journal:  Oncologist       Date:  2011-03-25

Review 4.  Castleman's disease--a two compartment model of HHV8 infection.

Authors:  Klaus-Martin Schulte; Nadia Talat
Journal:  Nat Rev Clin Oncol       Date:  2010-07-06       Impact factor: 66.675

5.  Update on HHV-8-Associated Malignancies.

Authors:  Meena Sunil; Erin Reid; Mary Jo Lechowicz
Journal:  Curr Infect Dis Rep       Date:  2010-03-26       Impact factor: 3.725

6.  Thalidomide for tocilizumab-resistant ascites with TAFRO syndrome.

Authors:  Shotaro Tatekawa; Koji Umemura; Ryuichi Fukuyama; Akio Kohno; Masafumi Taniwaki; Junya Kuroda; Yoshihisa Morishita
Journal:  Clin Case Rep       Date:  2015-04-22

7.  Radiotherapy of unicentric mediastinal Castleman's disease.

Authors:  Yue-Min Li; Peng-Hui Liu; Yu-Hai Zhang; Huo-Sheng Xia; Liang-Liang Li; Yi-Mei Qu; Yong Wu; Shou-Yun Han; Guo-Qing Liao; Yong-Dong Pu
Journal:  Chin J Cancer       Date:  2011-05

8.  Efficacy of bortezomib and thalidomide in the recrudescent form of multicentric mixed-type Castleman's disease.

Authors:  Q Lin; B Fang; H Huang; F Yu; X Chai; Y Zhang; J Zhou; Q Xia; Y Li; Y Song
Journal:  Blood Cancer J       Date:  2015-03-20       Impact factor: 11.037

Review 9.  Update and new approaches in the treatment of Castleman disease.

Authors:  Kah-Lok Chan; Stephen Lade; H Miles Prince; Simon J Harrison
Journal:  J Blood Med       Date:  2016-08-03

Review 10.  Multicentric Castleman disease and the evolution of the concept.

Authors:  Ting Zhou; Hao-Wei Wang; Stefania Pittaluga; Elaine S Jaffe
Journal:  Pathologica       Date:  2021-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.